Gennex Laboratories Ltd - ESG Rating & Company Profile powered by AI
The webpage contains a Q&A section about Gennex Laboratories Ltd. This SDG rating for Gennex Laboratories Ltd indicates the company's transparency towards the United Nations Sustainable Development Goals. Jump to the end of this page for potential risks for Gennex Laboratories Ltd based on industry, location and marketcap.
Gennex Laboratories Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1810 | XBiotech Inc | 1.1 | Low |
| 1826 | Mitsubishi Tanabe Pharma Corp | 1.0 | Low |
| 1827 | Gennex Laboratories Ltd | 0.9 | Low |
| 1827 | CannTrust Holdings Inc | 0.9 | Low |
| 1827 | Cannabis Poland SA | 0.9 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Gennex Laboratories Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Gennex Laboratories Ltd disclose current and historical energy intensity?
Does Gennex Laboratories Ltd report the average age of the workforce?
Does Gennex Laboratories Ltd reference operational or capital allocation in relation to climate change?
Does Gennex Laboratories Ltd disclose its ethnicity pay gap?
Does Gennex Laboratories Ltd disclose cybersecurity risks?
Does Gennex Laboratories Ltd use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Gennex Laboratories Ltd offer flexible work?
Does Gennex Laboratories Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Gennex Laboratories Ltd disclose the number of employees in R&D functions?
Does Gennex Laboratories Ltd plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Gennex Laboratories Ltd conduct supply chain audits?
Does Gennex Laboratories Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Gennex Laboratories Ltd conduct 360 degree staff reviews?
Does Gennex Laboratories Ltd disclose the individual responsible for D&I?
Does Gennex Laboratories Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Gennex Laboratories Ltd disclose current and / or historical scope 2 emissions?
Does Gennex Laboratories Ltd disclose water use targets?
Does Gennex Laboratories Ltd have careers partnerships with academic institutions?
Did Gennex Laboratories Ltd have a product recall in the last two years?
Does Gennex Laboratories Ltd disclose incidents of discrimination?
Does Gennex Laboratories Ltd allow for Work Councils/Collective Agreements to be formed?
Has Gennex Laboratories Ltd issued a profit warning in the past 24 months?
Does Gennex Laboratories Ltd disclose parental leave metrics?
Does Gennex Laboratories Ltd disclose climate scenario or pathway analysis?
Does Gennex Laboratories Ltd disclose current and / or historical scope 1 emissions?
Does Gennex Laboratories Ltd explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Gennex Laboratories Ltd disclose the pay ratio of women to men?
Does Gennex Laboratories Ltd support suppliers with sustainability related research and development?
Does Gennex Laboratories Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Gennex Laboratories Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Gennex Laboratories Ltd involved in embryonic stem cell research?
Does Gennex Laboratories Ltd disclose GHG and Air Emissions intensity?
Does Gennex Laboratories Ltd disclose its waste policy?
Does Gennex Laboratories Ltd report according to TCFD requirements?
Does Gennex Laboratories Ltd plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Gennex Laboratories Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Gennex Laboratories Ltd disclose energy use targets?
Does Gennex Laboratories Ltd disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does Gennex Laboratories Ltd have a policy relating to cyber security?
Potential Risks for Gennex Laboratories Ltd
These potential risks are based on the size, segment and geographies of the company.
Gennex Laboratories Limited engages in the manufacturing and selling of bulk drugs, intermediates, and biotech products in India and internationally. The company offers active pharmaceutical ingredients, including Guaifenesin; Methocarbamol; Fluconazole; Phenazopyridine Hcl; Allopurinol; and Ketoconazole. Its pipeline products include Melitracen Hydrochloride; Flupentixol Di-Hydrochloride; Domperidone; Potassium Guaiacol Sulphonate; Mefenamic Acid; Melitracen; and Chlorphenesin. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.